|Articles|March 18, 2020
Three Key Critical Considerations Before Embarking on Decentralized Trials
Author(s)Oracle
- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
Related Content
Trending on PharmExec
1
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
2
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
3
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
4
The Pharma Patent Cliff Explained: What It Is and How Companies Navigate It
5